Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells

British Journal of Cancer

Volumn 95, Issue 8, 2006, Pages 1038-1046

  Fabian, I ^a   Reuveni, D ^a   Levitov, A ^a   Halperin, D ^a   Priel, E ^b   Shalit, I ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Angiogenesis; Chemotherapeutic drugs; Cytotoxicity; Topoisomerase II

Indexed keywords

CASPASE 3; CHEMOKINE; CYTOKINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOCORTIN 5; MOXIFLOXACIN; QUINOLONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LOW DRUG DOSE; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AZA COMPOUNDS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II; DNA, SUPERHELICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; JURKAT CELLS; PLASMIDS; QUINOLINES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750200520     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603355     Document Type: Article

References (36)

1. Aceves M, Duenas A, Gomez C, San Vicente E, Crespo MS, Garcia-Rodriguez C (2004) A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. Immunology 173: 5721-5729
2. Aflalo E, Seri I, Segal S, Gazit A, Priel E (1994) Inhibition of topoisomerase I activity tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action. Cancer 54: 5138-5142
3. 2-cell cycle, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Cancer Res 6: 891-900
4. Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood Jr DP, Sarkar FH (2003) Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol 22: 787-794
5. Bakshi RP, Galande S, Muniyappa K (2001) Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase. Crit Rev Biochem Mol Biol 36: 1-37
6. Bendetz-Nezer S, Gazit A, Priel E (2004) DNA topoisomerase I as one of the cellular targets of certain tyrphostin derivatives. Mol Pharmacol 66: 627-634
7. Berger JM, Wang JC (1996) Recent developments in DNA topoisomerase II structure and mechanism. Curr Opin Struct Biol 6: 84-90
8. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokines 12: 78-85
9. Bromberg KD, Burgin AB, Osheroff N (2003a) Quinolone action against human topoisomerase II alpha: stimulation of enzyme-mediated double-stranded DNA cleavage. Biochemistry 42: 3393-3398
10. Bromberg KD, Burgin AB, Osheroff N (2003b) A two-drug model for etoposide action against human topoisomerase II alpha. J Biol Chem 278: 7406-7412
11. Darst M, Al-Hassani M, Li T, Yi Q, Travers JM, Lewis DA, Travers JB (2004) Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol 172: 6330-6335
12. Elsea SH, Westergaard M, Burden DA, Lomenick JP, Osheroff N (1997) Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs. Biochemistry 36: 2919-2924
13. El-Rayes BF, Grignon R, Aslam N, Aranha O, Sarkar FH (2002) Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells. Int J Oncol 21: 207-211
14. Fry AM, Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, Masters JR, Hickson ID (1991) Relationship between topoisomerase-II level and chemosensitivity in human tumour cell lines. Cancer Res 51: 6592-6595
15. 2, in human leukemia cells. Biochem Pharmacol 63: 1325-1335
16. Handle KR (1998) Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1400: 173-184
17. Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D (2002) Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 86: 443-448
18. Kagan VE, Kuzmenko AI, Tyurina YY, Shvedova AA, Matsura T, Yalowich JC (2001) Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role ofmyeloperoxidase. Cancer Res 6: 7777-7784
19. Kamat AM, DeHaven JI, Lamm DL (1999) Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology 54: 56-61
20. Kawagishi C, Kurosaka K, Watanabe N, Kobayashi Y (2001) Cytokine production by macrophages in association with phagocytosis of etoposide-treated P388 cells in vitro and in vivo. Biophys Acta 1541: 221-230
21. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE (1998) Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthoped Res 16: 509-512
22. Mizukami YJo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, Lynch MP, Rueda BR, Chung DC (2005) Induction of interleukin-8 preserves the angiogenic response in HIF-1 alpha-deficient colon cancer cells. Nat Med 11: 92-97
23. Perrone CE, Takahashi KC, Williams GM (2002) Inhibition of human topoisomerase II alpha by fluoroquinolones and ultraviolet A irradiation. Toxicol Sci 69: 6-22
24. Pestka J, Uzarski RL, Islam Z (2005) Induction of apoptosis and cytokine production in the Jurkat human T cells by deoxynivalenol: role of mitogen-activated protein kinases and comparison to other 8- ketotrichothecenes. Toxicology 206: 207-219
25. Ren Y, Cao B, Law S, Xie Y, Lee Py, Cheung L, Chen Y, Huang X, Chan HM, Zhao P, Luk J, Woude GV, Wong J (2005) Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinoma. Clin Cancer Res 11: 6190-6197
26. Robinson MJ, Martin BA, Gootz TD, McGuirk PR, Moynihan M, Sutcliffe JA, Osheroff N (1991) Effects of quinolone derivatives on eukaryotic topoisomerase-II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. J Biol Chem 266: 14585-14592
27. Shalit I, Halperin D, Haite D, Levitov A, Romano J, Osherov N, Fabian I (2006) Anti-inflammatory effects of moxifloxacin on IL-8, IL-1β and TNF-α secretion and NFκB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. J Antimicrob Chemother 57: 230-235
28. Shalit I, Horev-Azaria L, Fabian I, Blau H, Kariv N, Shechtman I, Alteraz H, Kletter Y (2002) Immunomodulatory and protective effects of moxifloxacin against Candida albicans induced bronchopneumonia in cyclophosphamide injected mice. Antimicrob Agents Chemother 46: 2442-2449
29. Shalit I, Nasrallah N, Bar-On S, Rabau M (1995) In vitro effect of ciprofloxacin and ofloxacin on murine and human colon carcinoma cell lines. Drugs 2(49 Suppl): 296-297
30. Trevino JG, Summy JM, Gray MJ, Nilsson MB, Lesslie DP, Baker CH, Gallick GE (2005) Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Res 65: 7214-7222
31. Usami I, Kubota M, Bessho R, Kataoka A, Koishi S, Watanabe K, Sawada M, Lin YW, Akiyama Y, Furusho K (1998) Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-κB activation. Biochem Pharmacol 55: 185-191
32. Villani F, Viola G, Vismara C, Laffranchi A, Di Russo A, Viviani S, Bonfante V (2002) Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease. Anticancer Res 22: 2403-2408
33. Weiss T, Shalit I, Blau H, Werber S, Halperin D, Levitov A, Fabian I (2004) Anti- inflammatory effects of MXF on activated human monocytic cells: inhibition of NFkB and MAPK activation and synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 48: 1974-1982
34. Werber S, Shalit I, Fabian I, Steuer G, Weiss T, Blau H (2005) MXF inhibits cytokine- induced nitric oxide production and down-regulates expression of iNOS, NFkB and MAP kinases in human respiratory epithelial cells. J Antimicrob Chemother 55: 293-300
35. Won JH, Park SY, Nam SG, Park HJ, Choi JW, Lee KT (2005) Inhibition of lipopolysaccharide- induced expression of inducible nitric oxide and cyclooxygenase-2 by chiisanoside via suppression of nuclear factor-kappa B activation in RAW 264.7 macrophage cells. Biol Pharm Bull 28: 1919-1924
36. Zehavi-Willner T, Shalit I (1992) The inhibitory effects of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. J Antimicrob Chemother 29: 323-328